Proc Natl Endocrinology inhibitor Acad Sci U S A 1992, 89:9367–9371.PubMedCrossRef 11. Zuckermann RN, Kerr JM, Kent SBH, Moos WH: Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J Am Chem Soc 1992, 114:10646–10647.CrossRef 12. Giuliani A, Rinaldi AC: Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell Mol Life Sci 2011, 68:2255–2266.PubMedCrossRef 13. Miller SM, Simon RJ, Ng S, Zuckermann RN, Kerr JM, Moos WH: Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg Med Chem Lett 1994, 4:2657–2662.CrossRef 14. Ryge TS, Frimodt-Moller N, Hansen PR: Antimicrobial activities
of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. Chemotherapy 2008, 54:152–156.PubMedCrossRef 15. Ryge TS, Hansen PR: Novel lysine-peptoid hybrids with antibacterial properties. J Pept Sci 2005, 11:727–734.PubMedCrossRef 16. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1–12.PubMedCrossRef 17. Hale JDF, Hancock NCT-501 REW: Alternative
mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti infect Ther 2007, 5:951–959.PubMedCrossRef 18. Peschel A, Sahl HG: The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006, 4:529–536.PubMedCrossRef 19. Rotem S, Radzishevsky IS, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A: Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J 2008, 22:2652–2661.PubMedCrossRef
20. Sarig PD184352 (CI-1040) H, Goldfeder Y, Rotem S, Mor A: Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl. Antimicrob Agents Chemother 2011, 55:688–695.PubMedCrossRef 21. Gunderson CW, Segall AM: DNA repair, a novel antibacterial target: Holliday junction-trapping peptides induce DNA damage and chromosome segregation defects. Mol Microbiol 2006, 59:1129–1148.PubMedCrossRef 22. Butala M, Zgur-Bertok D, Busby SJ: The bacterial LexA transcriptional repressor. Cell Mol Life Sci 2009, 66:82–93.PubMedCrossRef 23. Cox MM: Regulation of bacterial RecA protein function. Crit Rev Biochem Mol Biol 2007, 42:41–63.PubMedCrossRef 24. Novick R: Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus . Virology 1967, 33:155–166.PubMedCrossRef 25. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, GDC-0068 clinical trial Mongodin EF, Sensabaugh GF, Perdreau-Remington F: Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus . Lancet 2006, 367:731–739.PubMedCrossRef 26.